Panntherapi Advances Epilepsy Treatment with PTI5803 Clinical Trial
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…